Matthew C. O’Reilly

Sep 30, 2024 | dx.doi.org | Christopher Russo |Kirsten Ruud |Daniel Zelch |Matthew C. O’Reilly

IntroductionClick to copy section linkSection link copied!Heterocycles are key components of more than 85% of biologically active compounds, and nitrogen-containing heterocycles are present in approximately 60% of today’s FDA approved drugs, making their ease of synthesis critical to the development of life-saving therapeutics.